NL-OMON29881
Not yet recruiting
Phase 4
A pilot study to investigate whether fatigue is a side effect of etanercept in patients with moderate to severe psoriasis - Pilot study on fatigue as a side effect of etanercept
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- psoriasis
- Sponsor
- Academisch Medisch Centrum
- Enrollment
- 160
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Adult patients at the outpatient clinic diagnosed psoriasis with a PASI score \*10
- •\- Patients selected for treatment with etanercept
- •\- Patients selected for treatment with narrowband UVB therapy
Exclusion Criteria
- •\- PASI\<10
- •\- unable to complete the questionnaires
- •\- uncontrolled co\-morbidity known to cause fatigue
- •\- concomitant medication known to have fatigue as aside effect
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
fatigue, and performance status in anaemic cancer patients undergoing cancer treatment.CTRI/2022/01/039371Aditi Sawant Dessai
Completed
Not Applicable
A prospective observational study about fatigue in patients with unresectable pancreatic cancer who receive nab-paclitaxel plus gemcitabine therapyPatients with unresectable pancreatic cancerJPRN-UMIN000021758Wakayama Medical University10
Recruiting
Not Applicable
An assessment of the association between fatigue, physical activity, psychological wellbeing and quality of life in breast cancer patients during and shortly after adjuvant chemotherapyfatigue and quality of life100276561000840110043413NL-OMON33404Medisch Centrum Leeuwarden50
Completed
Not Applicable
A clinical study to evaluate the anti-fatigue effect of hydrogen waterJPRN-UMIN000027700Soiken Inc.20
Completed
Not Applicable
A clinical study to evaluate the anti-fatigue effect of S-allylcysteineJPRN-UMIN000030501Soiken Inc.24